Tag: CPAP alternative

BRISBANE, Australia – Oventus Medical has signed a new virtual lab-in-lab agreement with Sleep Metrics, a Portland, Ore.-based provider of sleep apnea testing and therapy, its fourth such agreement. Through the agreement, Sleep Metrics is now able to offer O2Vent therapy as a treatment alternative to patients who refuse CPAP therapy or find it challenging. “There are tremendous synergies with our VLIL model and Sleep Metrics’ existing at-home OSA testing,”...

BRISBANE, Australia – Oventus Medical has signed on its first member of VGM & Associates: InHome Oxygen and Medical Equipment in Pennsylvania. Per the agreement, InHome Oxygen will offer O2Vent therapy as a treatment alternative to patients who find CPAP therapy challenging. “We definitely see a need to provide alternative treatment for the many patients that refuse or struggle with PAP therapies,” said Robert Campitelli, president and...

BRISBANE, Australia - Oventus Medical has signed agreements with two new sleep groups, Tri Hospital Sleep and Ontario Sleep Care, both in Canada. Under these agreements Oventus O2Vent devices will be offered to patients at nine sites. “These businesses have been delivering high quality respiratory care for many years, even decades,” said Dr. Chris Hart, founder and CEO. “Oventus is proud that such well-respected sleep groups in North America have chosen to strengthen their existing...

DEERFIELD BEACH, Fla. - More than 70% of 200 people with mild to moderate sleep apnea who were recently surveyed would prefer to try the Bongo Rx over traditional CPAP therapy if given the choice, according to AirAvant Medical, maker of the Bongo Rx. “I feel the results of the Qualtrics Survey reflect that mild to moderate OSA sufferers want a simple and effective alternative to traditional CPAP,” said Bruce Sher, president of AirAvant Medical. “It's gratifying that years of effort...

DEERFIELD BEACH, Fla. - AirAvant Medical will share research findings on the efficacy and safety of its Bongo Rx at the SLEEP 2019 conference, June 8-12 in San Antonio. “Long-term CPAP compliance continues to range from 30% to 70%, but we believe the Bongo Rx can help level the playing field for those with mild to moderate sleep apnea,” said Ron Richard, co-founder and director. “Not only can this product work for non-compliant patients, it can be a great supplemental option for...

MINNEAPOLIS - Inspire Medical Systems has announced the results of a study that shows Medicare-aged patients, in particular, respond well to and adhere to its therapy. The study, led by physicians at the University of Alabama at Birmingham, followed 235 Medicare-aged patients and 365 younger-aged patients and collected information on sleep apnea severity, quality of life and any complications with the procedure. The results demonstrated that, while all patients positively responded to Inspire therapy,...

DEERFIELD BEACH, Fla. - AirAvant Medical says its flagship product, Bongo Rx, is now available for patients requiring treatment for mild to moderate obstructive sleep apnea. The Bongo Rx, cleared by the U.S. Food and Drug Administration, seals comfortably in the nose and works by creating back pressure when an OSA sufferer exhales. “For compliant CPAP patients, the Bongo Rx may provide a supplemental treatment option to complement their lifestyle,” said Javier Collazo, vice president....

MINNETONKA, Minn. - An alternative to CPAP therapy has been approved by CMS for a new technology add-on payment to hospitals. The NTAP program will provide additional reimbursement on top of the standard Medicare Severity Diagnosis Related Group payment to hospitals under the Medicare Hospital Inpatient Prospective System for Respicardia's remed? System, an implantable device that treats the effects of central sleep apnea by restoring a more normal breathing patter during sleep. The add-on payment...

MINNEAPOLIS - Inspire Medical Systems, the maker of FDA-approved neurostimulation technology that provides treatment for moderate to severe OSA, has filed paperwork for an initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Inspire has applied to list its common stock on the New York Stock Exchange under the ticker symbol “INSP.” BofA Merrill Lynch and Goldman Sachs & Co. LLC are serving as...